Back to Search
ANTHONY OLSZANSKI, M.D.
M.D.
Medical Oncology Physician
NPI: 1447483433IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD438190(PA)
CMS Specialties
PrimaryHEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY
Additional
Education
RUTGERS NEW JERSEY MEDICAL SCHOOL
Class of 1996
Research & Publications (4)
Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
PMID 19597027·J Clin Oncol·2009
3-trial
Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxel.
PMID 17545535·Clin Cancer Res·2007
3-trial
Modulation of cell cycle progression in human tumors: a pharmacokinetic and tumor molecular pharmacodynamic study of cisplatin plus the Chk1 inhibitor UCN-01 (NSC 638850).
PMID 17145831·Clin Cancer Res·2006
3-trial
Docetaxel and gemcitabine: a nonplatinum combination for non small-cell lung cancer.
PMID 14725737·Clin Lung Cancer·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 333 COTTMAN AVE, MED STAFF OFFICE
PHILADELPHIA, PA 19111 - Phone
- (215) 728-6900
Quick Facts
- NPI
- 1447483433
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 4
Are you this provider?
Claim Your Profile